Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabine Linn

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
EMBO Molecular Medicine|October 30, 2023
Luminal breast cancer identity is determined by loss of glucocorticoid receptor activityStefan Prekovic, Theofilos Chalkiadakis, Merel Roest, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast CancerLouise Walsh, Kathryn E Haley, Bruce Moran, et al.
Cancer Research|April 30, 2017
Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast CancerBo Li, Triona Ni Chonghaile, Yue Fan, et al.
Nature|December 5, 2024
The oestrous cycle stage affects mammary tumour sensitivity to chemotherapyLaura Bornes, Lennart J van Winden, Veerle C M Geurts, et al.
Breast (Edinburgh, Scotland)|April 5, 2025
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBCElena Laakmann, Marcus Schmidt, Kristina Lübbe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2019
EZH2 Is Overexpressed in <i>BRCA1</i>-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based ChemotherapyJulian Puppe, Mark Opdam, Philip C Schouten, et al.
Journal of Hematology & Oncology|April 18, 2021
Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based studyAnouk H Eijkelboom, Linda de Munck, Marie-Jeanne T F D Vrancken Peeters, et al.
Cell|April 9, 2016
A Vulnerability of a Subset of Colon Cancers with Potential Clinical UtilityLoredana Vecchione, Valentina Gambino, Jonne Raaijmakers, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2025
Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort studyIsotta Martha Magaton, Eva Blondeaux, Anne-Sophie Hamy, et al.
Journal of the National Cancer Institute|July 7, 2025
Breastfeeding after breast cancer in young BRCA carriersEva Blondeaux, Virginia Delucchi, Elene Mariamidze, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
EMBO Molecular Medicine|October 30, 2023
Luminal breast cancer identity is determined by loss of glucocorticoid receptor activityStefan Prekovic, Theofilos Chalkiadakis, Merel Roest, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2019
BET Inhibition as a Rational Therapeutic Strategy for Invasive Lobular Breast CancerLouise Walsh, Kathryn E Haley, Bruce Moran, et al.
Cancer Research|April 30, 2017
Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast CancerBo Li, Triona Ni Chonghaile, Yue Fan, et al.
Nature|December 5, 2024
The oestrous cycle stage affects mammary tumour sensitivity to chemotherapyLaura Bornes, Lennart J van Winden, Veerle C M Geurts, et al.
Breast (Edinburgh, Scotland)|April 5, 2025
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBCElena Laakmann, Marcus Schmidt, Kristina Lübbe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2019
EZH2 Is Overexpressed in <i>BRCA1</i>-like Breast Tumors and Predictive for Sensitivity to High-Dose Platinum-Based ChemotherapyJulian Puppe, Mark Opdam, Philip C Schouten, et al.
Journal of Hematology & Oncology|April 18, 2021
Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based studyAnouk H Eijkelboom, Linda de Munck, Marie-Jeanne T F D Vrancken Peeters, et al.
Cell|April 9, 2016
A Vulnerability of a Subset of Colon Cancers with Potential Clinical UtilityLoredana Vecchione, Valentina Gambino, Jonne Raaijmakers, et al.
European Journal of Cancer (Oxford, England : 1990)|April 29, 2025
Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort studyIsotta Martha Magaton, Eva Blondeaux, Anne-Sophie Hamy, et al.
Journal of the National Cancer Institute|July 7, 2025
Breastfeeding after breast cancer in young BRCA carriersEva Blondeaux, Virginia Delucchi, Elene Mariamidze, et al.
Pageof 5